Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

Delivery of short interfering RNAs (siRNAs) remains a key challenge in the development of RNA interference (RNAi) therapeutics. A better understanding of the mechanisms of siRNA cellular uptake, intracellular transport and endosomal release could critically contribute to the improvement of delivery methods. Here we monitored the uptake of lipid nanoparticles (LNPs) loaded with traceable siRNAs in different cell types in vitro and in mouse liver by quantitative fluorescence imaging and electron microscopy. We found that LNPs enter cells by both constitutive and inducible pathways in a cell type-specific manner using clathrin-mediated endocytosis as well as macropinocytosis. By directly detecting colloidal-gold particles conjugated to siRNAs, we estimated that escape of siRNAs from endosomes into the cytosol occurs at low efficiency (1–2%) and only during a limited window of time when the LNPs reside in a specific compartment sharing early and late endosomal characteristics. Our results provide insights into LNP-mediated siRNA delivery that can guide development of the next generation of delivery systems for RNAi therapeutics.

[1]  Young Jik Kwon,et al.  Efficient and targeted delivery of siRNA in vivo , 2010, The FEBS journal.

[2]  C. Alpers,et al.  Novel siRNA Delivery System to Target Podocytes In Vivo , 2010, PloS one.

[3]  Y. Kalaidzidis,et al.  Rab Conversion as a Mechanism of Progression from Early to Late Endosomes , 2005, Cell.

[4]  Shubiao Zhang,et al.  Non-viral vectors for the mediation of RNAi. , 2012, Bioorganic chemistry.

[5]  T. Kirchhausen,et al.  Dynasore, a cell-permeable inhibitor of dynamin. , 2006, Developmental cell.

[6]  John Maraganore,et al.  A status report on RNAi therapeutics , 2010, Silence.

[7]  W. Pardridge,et al.  Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. , 2009, Molecular pharmaceutics.

[8]  Ding Wang,et al.  Construction and Characterization of a Lipotes vexillifer Genomic DNA BAC Library , 2007, Zoological science.

[9]  K. G. Rajeev,et al.  Modulation of thermal stability can enhance the potency of siRNA , 2010, Nucleic acids research.

[10]  M. Lindsay,et al.  The Tetraspanin CD 63 / lamp 3 Cycles between Endocytic and Secretory Compartments in Human Endothelial Cells , 2000 .

[11]  W. Wickner,et al.  Excess vacuolar SNAREs drive lysis and Rab bypass fusion , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Metspalu,et al.  Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo , 2011, Nucleic acids research.

[13]  S. Futaki,et al.  Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Marino Zerial,et al.  Identification of the Switch in Early-to-Late Endosome Transition , 2010, Cell.

[15]  F. Maxfield,et al.  Membrane transport in the endocytic pathway. , 1995, Current opinion in cell biology.

[16]  P. Cullis,et al.  On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.

[17]  Boris Klebanov,et al.  Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  M. Farrer,et al.  In vivo silencing of alpha-synuclein using naked siRNA , 2008, Molecular neurodegeneration.

[19]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[20]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[21]  Kathryn A. Whitehead,et al.  Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.

[22]  Shigeo Matsuda,et al.  Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo** , 2012, Angewandte Chemie.

[23]  M. Rosen,et al.  Connexin‐specific cell‐to‐cell transfer of short interfering RNA by gap junctions , 2005, The Journal of physiology.

[24]  Fanyu Meng,et al.  Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. , 2011, The Biochemical journal.

[25]  Y. Kalaidzidis,et al.  Reconstitution of Rab- and SNARE-dependent membrane fusion by synthetic endosomes , 2009, Nature.

[26]  A. Sachs,et al.  Quantitative evaluation of siRNA delivery in vivo. , 2010, RNA.

[27]  M. Zerial,et al.  Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12V , 2012, Molecular biology of the cell.

[28]  J. Zeman,et al.  quantitative evaluation of by , 2010 .

[29]  M. Lindsay,et al.  The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. , 2000, Molecular biology of the cell.

[30]  S. Futaki,et al.  Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA. , 2011, Biomaterials.

[31]  J. Burchard,et al.  RNA-Induced Silencing Complex-Bound Small Interfering RNA Is a Determinant of RNA Interference-Mediated Gene Silencing in Mice , 2011, Molecular Pharmacology.

[32]  K. G. Rajeev,et al.  Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  Sarah Seifert,et al.  Rab5 is necessary for the biogenesis of the endolysosomal system in vivo , 2012, Nature.

[34]  M. Stoffel,et al.  Mechanisms and optimization of in vivo delivery of lipophilic siRNAs , 2007, Nature Biotechnology.

[35]  M. Damha,et al.  Oligoribonucleotide synthesis. The silyl-phosphoramidite method. , 1993, Methods in molecular biology.

[36]  Y. Nagasaki,et al.  Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure. , 2009, Biomacromolecules.

[37]  G. Hannon,et al.  Small RNA sorting: matchmaking for Argonautes , 2011, Nature Reviews Genetics.

[38]  L. Palmer,et al.  Stabilized plasmid-lipid particles: construction and characterization , 1999, Gene Therapy.

[39]  Gert Storm,et al.  Sheddable Coatings for Long-Circulating Nanoparticles , 2007, Pharmaceutical Research.

[40]  H. McMahon,et al.  Mechanisms of endocytosis. , 2009, Annual review of biochemistry.

[41]  M. Zerial,et al.  The Rab5 Effector Rabankyrin-5 Regulates and Coordinates Different Endocytic Mechanisms , 2004, PLoS biology.

[42]  U. Greber,et al.  Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake , 2002, The Journal of cell biology.

[43]  J. Kjems,et al.  A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity , 2009, Nucleic acids research.

[44]  K. G. Rajeev,et al.  Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.

[45]  T. Park,et al.  Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[46]  N. Svrzikapa,et al.  In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR) , 2010, Silence.

[47]  B. Schnierle,et al.  Selective gene silencing by viral delivery of short hairpin RNA , 2010, Virology Journal.

[48]  D. Dykxhoorn,et al.  Breaking down the barriers: siRNA delivery and endosome escape , 2010, Journal of Cell Science.

[49]  Robert Langer,et al.  Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates , 2008, Proceedings of the National Academy of Sciences.

[50]  H. Mahmutefendic,et al.  Murine Cytomegalovirus Perturbs Endosomal Trafficking of Major Histocompatibility Complex Class I Molecules in the Early Phase of Infection , 2010, Journal of Virology.

[51]  S. Futaki,et al.  Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.